Literature DB >> 8624281

Occurrence of cancer in women with Turner syndrome.

H Hasle1, J H Olsen, J Nielsen, J Hansen, U Friedrich, N Tommerup.   

Abstract

A study of cancer incidence in a cohort of 597 women with Turner syndrome (TS) and a virtually complete follow-up is presented. The cohort was established from the Danish Cytogenetic Register. Information on cancer incidence was obtained from the Danish Cancer Registry and compared with the expected number calculated from the age-, period- and site-specific cancer rates for Danish women. A total of 21 neoplasms was observed, of which 13 occurred more than 1 year after diagnosis of TS, corresponding to a relative risk of cancer of 1.1. Wilms' tumour was the only identified childhood cancer. No case of gonadoblastoma or dysgerminoma was identified in the 29 women with a Y chromosome or in the women in whom no Y chromosome material was detected by standard cytogenetic methods, suggesting that the risk of ovarian germ cell tumours may be lower than previously estimated. Colon cancer was observed in five patients (relative risk 6.9, 95% confidence interval 2.2-16.2). Further studies are needed to assess whether colon cancer in TS is related to Turner-associated genes on the sex chromosome(s).

Entities:  

Mesh:

Year:  1996        PMID: 8624281      PMCID: PMC2074404          DOI: 10.1038/bjc.1996.222

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  30 in total

1.  Turner's syndrome associated with chronic inflammatory bowel disease. A case report and review of the literature.

Authors:  J Knudtzon; S Svane
Journal:  Acta Med Scand       Date:  1988

2.  Gastric carcinoma and Turner's syndrome.

Authors:  D Siegler
Journal:  Postgrad Med J       Date:  1975-06       Impact factor: 2.401

3.  45,XO Turner's syndrome, Wilm's tumor and imprforate anus.

Authors:  B Say; S Balci; E Tunçbilek
Journal:  Humangenetik       Date:  1971

4.  Nongonadal neoplasia in Turner's syndrome.

Authors:  W Wertelecki; J F Fraumeni; J J Mulvihill
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

5.  45,XO Turner's syndrome and leukaemia.

Authors:  W Wertelecki; J R Shapiro
Journal:  Lancet       Date:  1970-04-11       Impact factor: 79.321

6.  Epithelioid sarcoma in XO-XX Turner's syndrome.

Authors:  J L Males; K C Lain
Journal:  Arch Pathol       Date:  1972-09

7.  Nonfamilial Turcot's syndrome associated with Turner's syndrome, multiple carcinomas of the tongue, and cancer of the colon.

Authors:  L Herrera-Ornelas; H Ochi; N Petrelli; A Mittelman; A A Sandberg
Journal:  J Surg Oncol       Date:  1984-12       Impact factor: 3.454

8.  Endometrial carcinoma in Turner's syndrome.

Authors:  M H Louka; R D Ross; J H Lee; G C Lewis
Journal:  Gynecol Oncol       Date:  1978-06       Impact factor: 5.482

9.  Basal cell nevus syndrome and Turner's syndrome in a patient.

Authors:  V C Andreev; N B Zlatkov
Journal:  Int J Dermatol       Date:  1971 Jan-Mar       Impact factor: 2.736

10.  Chronic myelogenous leukemia in the monosomic cell line of a fertile Turner syndrome mosaic (45,X/46,XX).

Authors:  R S Chaganti; R B Bailey; S C Jhanwar; Z A Arlin; B D Clarkson
Journal:  Cancer Genet Cytogenet       Date:  1982-03
View more
  16 in total

1.  Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: The NHLBI GenTAC registry.

Authors:  Siddharth K Prakash; Carolyn A Bondy; Cheryl L Maslen; Michael Silberbach; Angela E Lin; Laura Perrone; Giuseppe Limongelli; Hector I Michelena; Eduardo Bossone; Rodolfo Citro; Scott A Lemaire; Simon C Body; Dianna M Milewicz
Journal:  Am J Med Genet A       Date:  2016-09-08       Impact factor: 2.802

2.  Sporadic aneuploidy in PHA-stimulated lymphocytes of Turner's syndrome patients.

Authors:  Orit Reish; Nirit Brosh; Rima Gobazov; Malka Rosenblat; Vitalia Libman; Maya Mashevich
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

3.  Cancer risk in persons with oral cleft--a population-based study of 8,093 cases.

Authors:  Camilla Bille; Jeanette Falck Winther; Andrea Bautz; Jeffrey C Murray; Jørn Olsen; Kaare Christensen
Journal:  Am J Epidemiol       Date:  2005-06-01       Impact factor: 4.897

Review 4.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

5.  New insights into the comorbid conditions of Turner syndrome: results from a long-term monocentric cohort study.

Authors:  A Gambineri; E Scarano; P Rucci; A Perri; F Tamburrino; P Altieri; F Corzani; C Cecchetti; P Dionese; E Belardinelli; D Ibarra-Gasparini; S Menabò; V Vicennati; A Repaci; G di Dalmazi; C Pelusi; G Zavatta; A Virdi; I Neri; F Fanelli; L Mazzanti; U Pagotto
Journal:  J Endocrinol Invest       Date:  2022-07-30       Impact factor: 5.467

6.  Chromosome-wide gene dosage rebalance may benefit tumor progression.

Authors:  Honglei Zhang; Xing Yang; Xu Feng; Haibo Xu; Qin Yang; Li Zou; Mei Yan; Dequan Liu; Xiaosan Su; Baowei Jiao
Journal:  Mol Genet Genomics       Date:  2018-03-15       Impact factor: 3.291

Review 7.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

8.  Small intestinal tubular adenoma in a pediatric patient with Turner syndrome.

Authors:  Wen-Juan Tang; Ying Huang; Lian Chen; Shan Zheng; Kui-Ran Dong
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

9.  Survival among people with Down syndrome: a nationwide population-based study in Denmark.

Authors:  Jin Liang Zhu; Henrik Hasle; Adolfo Correa; Diana Schendel; J M Friedman; Jørn Olsen; Sonja A Rasmussen
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

10.  Low risk of solid tumors in persons with Down syndrome.

Authors:  Henrik Hasle; Jan M Friedman; Jørgen H Olsen; Sonja A Rasmussen
Journal:  Genet Med       Date:  2016-03-31       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.